Hot Pursuit     07-Jun-24
Granules India Ltd soars 1.77%, Gains for third straight session
Granules India Ltd is quoting at Rs 476.6, up 1.77% on the day as on 12:49 IST on the NSE. The stock is up 70.31% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

Granules India Ltd is up for a third straight session in a row. The stock is quoting at Rs 476.6, up 1.77% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.78% on the day, quoting at 23226.9. The Sensex is at 76478.93, up 1.87%. Granules India Ltd has added around 16% in last one month.

Meanwhile, Nifty Pharma index of which Granules India Ltd is a constituent, has added around 3.55% in last one month and is currently quoting at 19232.1, up 1.5% on the day. The volume in the stock stood at 16.27 lakh shares today, compared to the daily average of 17 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 476.5, up 1.4% on the day. Granules India Ltd is up 70.31% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

The PE of the stock is 26.01 based on TTM earnings ending March 24.

Previous News
  Granules India Ltd up for third consecutive session
 ( Hot Pursuit - 01-Oct-24   13:05 )
  Granules India unveils its Mobile Cancer Screening Unit at AIG Hospitals
 ( Corporate News - 24-Sep-24   14:40 )
  Granules India Ltd drops for fifth straight session
 ( Hot Pursuit - 17-Sep-24   13:35 )
  Granules India's Gagillapur FD facility completes USFDA inspection
 ( Corporate News - 12-Sep-24   15:19 )
  Granules India tumbles after Hyderabad facility gets six observations from USFDA
 ( Hot Pursuit - 12-Sep-24   15:15 )
  Granules India Ltd leads losers in 'A' group
 ( Hot Pursuit - 12-Sep-24   15:00 )
  Granules India’s Gagillapur facility completes USFDA inspection with 6 observations
 ( Hot Pursuit - 09-Sep-24   10:30 )
  Granules India Ltd soars 1.63%, up for third straight session
 ( Hot Pursuit - 21-Aug-24   13:05 )
  Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
 ( Corporate News - 20-Aug-24   15:24 )
  Granules India rises on USFDA nod for oral drug Glycopyrrolate
 ( Hot Pursuit - 20-Aug-24   14:00 )
  Granules India receives US FDA nod for depression treatment drug Trazodone
 ( Hot Pursuit - 09-Aug-24   14:52 )
Other Stories
  Malu Paper Mills Ltd leads gainers in 'B' group
  03-Oct-24   12:15
  ITD Cementation India Ltd leads gainers in 'A' group
  03-Oct-24   12:00
  J.Kumar Infra rises on securing LoA for road project in Thane
  03-Oct-24   11:45
  Transformers and Rectifiers gains on bagging order worth Rs 565-cr
  03-Oct-24   11:16
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  Hero MotoCorp total sales spurts 19% YoY in Sep
  03-Oct-24   10:50
  Yes Bank's loan book rises to Rs 2.36 lakh crore in Q2 FY25; deposits up over 18% YoY
  03-Oct-24   10:46
  Dabur India slides on forecasting mid-single digit revenue dip in Q2 FY25
  03-Oct-24   10:46
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
Back Top